COVID-19 nặng, hội chứng viêm đa hệ ở trẻ em và bệnh Kawasaki: cơ chế miễn dịch, biểu hiện lâm sàng và quản lý

Jindal AK, Pilania RK, Prithvi A, Guleria S, Singh S (2019) Kawasaki disease: characteristics, diagnosis and unusual presentations. Expert Rev Clin Immunol Singh S, Jindal AK, Pilania RK (2018) Diagnosis of Kawasaki disease. Int J Rheum Dis 21(1):36–44 Singh S, Vignesh P, Burgner D (2015) The epidemiology of Kawasaki disease: a global update. Arch Dis Child 100(11):1084–1088 Rowley AH, Baker SC, Shulman ST, Garcia FL, Guzman-Cottrill JA, Chou P et al (2004) Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis 190(4):856–865 Rowley AH, Baker SC, Shulman ST, Fox LM, Takahashi K, Garcia FL et al (2005) Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis 192(10):1757–1766 Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM et al (2008) RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS ONE 3(2):e1582 Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 395(10239):1771–1778 Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N et al (2020) Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 79(8):999–1006 Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S et al (2020) Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health 4(9):662–668 Belot A, Antona D, Renolleau S, Javouhey E, Hentgen V, Angoulvant F et al (2020) SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill 25(22):2001010 Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF et al (2020) Multisystem inflammatory syndrome in US Children and adolescents. N Engl J Med 383(4):334–346 Abrams JY, Godfred-Cato SE, Oster ME, Chow EJ, Koumans EH, Bryant B et al (2020) Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systematic review. J Pediatr 226(45–54):e1 Akca UK, Kesici S, Ozsurekci Y, Aykan HH, Batu ED, Atalay E, et al (2020) Kawasaki-like disease in children with COVID-19. Rheumatol Int 40(12):2105–2115 Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S et al (2020) SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics 146(2):e20201711 CDC (2020) Multisystem Inflammatory Syndrome in Children (MIS-C) [Internet]. Centers for Disease Control and Prevention. https://www.cdc.gov/mis-c/hcp/. Accessed 11 Aug 2020 Multisystem inflammatory syndrome in children and adolescents with COVID-19 (2020) Scientific brief: World Health Organisation. https://www.who.int/publications-detail/multisystem-inflammatory-syndrome-in-children-andadolescents-with-covid-19. Accessed 15 May 2020. Royal College of Pediatrics and Child Health (2020) Guidance—Pediatric multisystem inflammatory syndrome temporally associated with COVID-19, 2020. https://www.rcpch.ac.uk/resources/guidance-pediatric-multisystem-inflammatory-syndrometemporally-associated-covid-19 Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417 Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS (2005) Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 191(4):492–498 Dijkman R, Jebbink MF, Gaunt E, Rossen JWA, Templeton KE, Kuijpers TW et al (2012) The dominance of human coronavirus OC43 and NL63 infections in infants. J Clin Virol 53(2):135–139 Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K et al (2018) Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010–2015 in Guangzhou. PLoS ONE 13(1):e0191789 Lau SKP, Woo PCY, Yip CCY, Tse H, Tsoi H, Cheng VCC et al (2006) Coronavirus HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 44(6):2063–2071 Chiu SS, Hung Chan K, Wing Chu K, Kwan SW, Guan Y, Man Poon LL et al (2005) Human Coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong. China Clin Infect Dis 40(12):1721–1729 Papa A, Papadimitriou E, de Souza Luna LK, Al Masri M, Souliou E, Eboriadou M et al (2007) Coronaviruses in children, Greece. Emerg Infect Dis 13(6):947–949 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280.e8 Muus C, Luecken MD, Eraslan G, Waghray A, Heimberg G, Sikkema L et al (2020) Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. BioRxiv 2020.04.19.049254 Han SB, Lee SY (2020) Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches. World J Pediatr. https://doi.org/10.1007/s12519-020-00360-6 (Epub ahead of print) Zhang Y, Xu J, Jia R, Yi C, Gu W, Liu P et al (2020) Protective humoral immunity in SARS-CoV-2 infected pediatric patients. Cell Mol Immunol 17(7):768–770 Chen J, Zhang ZZ, Chen YK, Long QX, Tian WG, Deng HJ et al (2020) The clinical and immunological features of pediatric COVID-19 patients in China. Genes Dis. https://doi.org/10.1016/j.gendis.2020.03.008 (Epub ahead of print) Henry BM, Benoit SW, de Oliveira MHS, Hsieh WC, Benoit J, Ballout RA et al (2020) Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): a pooled analysis and review. Clin Biochem 81:1–8 Wu H, Zhu H, Yuan C, Yao C, Luo W, Shen X et al (2020) Clinical and immune features of hospitalized pediatric patients with coronavirus disease 2019 (COVID-19) in Wuhan, China. JAMA Netw Open 3(6):e2010895 Li Y, Deng W, Xiong H, Li H, Chen Z, Nie Y et al (2020) Immune-related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan. Pediatr Pulmonol. https://doi.org/10.1002/ppul.24907 (Epub ahead of print) Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D et al (2020) SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 183(4):729–737 Kanitakis J, Lesort C, Danset M, Jullien D (2020) Chilblain-like acral lesions during the COVID-19 pandemic (“COVID toes”): histologic, immunofluorescence, and immunohistochemical study of 17 cases. J Am Acad Dermatol 83(3):870–875 Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Gómez-Zubiaur A, Pérez-Mesonero R, Bandini M et al (2020) Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology. J Eur Acad Dermatol Venereol 34(10):e572–e574 Herman A, Peeters C, Verroken A, Tromme I, Tennstedt D, Marot L et al (2020) Evaluation of chilblains as a manifestation of the COVID-19 pandemic. JAMA Dermatol 156(9):998–1003 Meena J, Yadav J, Saini L, Yadav A, Kumar J (2020) Clinical features and outcome of SARS-CoV-2 infection in children: a systematic review and meta-analysis. Indian Pediatr 57(9):820–826 Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S et al (2020) Detection of Covid-19 in children in early January 2020 in Wuhan. China N Engl J Med 382(14):1370–1371 Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395(10237):1607–1608 Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al (2020) Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.120.048360 (Epub ahead of print) Centers for Disease Control and Prevention. Emergency preparedness and response: Health alert network. https://emergency.cdc.gov/han/2020/han00432.asp Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al (2020) Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 324(3):259–269 Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F et al (2020) Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 369:m2094 Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G et al (2020) Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 4(9):669–677 Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J, Roberts JE et al (2020) Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Investig. https://doi.org/10.1172/JCI141113 (Epub ahead of print. PMID: 32701511) Pilania RK, Bhattarai D, Singh S (2018) Controversies in diagnosis and management of Kawasaki disease. World J Clin Pediatr 7(1):27–35 Dionne A, Dahdah N (2018) Myocarditis and Kawasaki disease. Int J Rheum Dis 21(1):45–49 Pilania RK, Jindal AK, Bhattarai D, Naganur SH, Singh S (2020) Cardiovascular involvement in Kawasaki disease is much more than mere coronary arteritis. Front Pediatr 8:526969. https://doi.org/10.3389/fped.2020.526969 Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, Milner JD (2020) Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA 324(3):294–296 Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG et al (2020) Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol 41(7):1391–1401. https://doi.org/10.1007/s00246-020-02391-2 Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S (2020) Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Child Basel Switz 7(7):69. https://doi.org/10.3390/children7070069 Bhat CS, Gupta L, Balasubramanian S, Singh S, Ramanan AV (2020) Hyperinflammatory syndrome in children associated with COVID-19: need for awareness. Indian Pediatr 57(10):929–935 Perez-Toledo M, Faustini SE, Jossi SE, Shields AM, Kanthimathinathan HK, Allen JD et al (2020) Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome. MedRxiv Prepr Serv Health Sci. https://doi.org/10.1101/2020.06.05.20123117 Rostad CA, Chahroudi A, Mantus G, Lapp SA, Teherani M, Macoy L, et al. Serology in children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19. medRxiv. 2020;2020.07.10.20150755. Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK (2016) Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. Rheumatol Int 36(4):551–559 McCrindle BW, Cifra B (2018) The role of echocardiography in Kawasaki disease. Int J Rheum Dis 21(1):50–55 Dusad S, Singhal M, Pilania RK, Suri D, Singh S (2020) CT Coronary Angiography studies after a mean follow-up of 3.8 years in children with Kawasaki disease and spontaneous defervescence. Front Pediatr 8:274. https://doi.org/10.3389/fped.2020.00274 Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, Levy Y, Sileo C et al (2020) Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series. Radiology. https://doi.org/10.1148/radiol.2020202288 (Epub ahead of print) Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H et al (2020) American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. https://doi.org/10.1002/art.41454 (Epub ahead of print) Pilania RK, Jindal AK, Guleria S, Singh S (2019) An update on treatment of Kawasaki disease. Curr Treat Opt Rheumatol 5(1):36–55 Riollano-Cruz M, Akkoyun E, Briceno-Brito E, Kowalsky S, Reed J, Posada R et al (2020) Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience. J Med Virol. https://doi.org/10.1002/jmv.26224 (Epub ahead of print) Ruscitti P, Berardicurti O, Di Benedetto P, Cipriani P, Iagnocco A, Shoenfeld Y, Giacomelli R (2020) Severe COVID-19, another piece in the puzzle of the hyperferritinemic syndrome. An immunomodulatory perspective to alleviate the storm. Front Immunol. 11:1130 Dhanalakshmi K, Venkataraman A, Balasubramanian S, Madhusudan M, Amperayani S, Putilibai S, et al. Epidemiological and Clinical Profile of Pediatric inflammatory multisystem syndrome—temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children. Indian Pediatr. 2020 (Epub ahead of print) Bell DM, Brink EW, Nitzkin JL, Hall CB, Wulff H, Berkowitz ID et al (1981) Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med 304(26):1568–1575 McIntosh K (2005) Coronaviruses in the limelight. J Infect Dis 191(4):489–491 Jordan-Villegas A, Chang ML, Ramilo O, Mejías A (2010) Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr Infect Dis J 29(8):770–772 Huang X, Huang P, Zhang L, Xie X, Xia S, Gong F et al (2015) Influenza infection and Kawasaki disease. Rev Soc Bras Med Trop 48(3):243–248 Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS (2005) Association between a novel human coronavirus and Kawasaki disease. J Infect Dis 191(4):499–502 Shimizu C, Shike H, Baker SC, Garcia F, van der Hoek L, Kuijpers TW et al (2005) Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J Infect Dis 192(10):1767–1771 Dominguez SR, Anderson MS, Glodé MP, Robinson CC, Holmes KV (2006) Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis 194(12):1697–1701 Lehmann C, Klar R, Lindner J, Lindner P, Wolf H, Gerling S (2009) Kawasaki disease lacks association with human coronavirus NL63 and human bocavirus. Pediatr Infect Dis J 28(6):553–554 Shirato K, Imada Y, Kawase M, Nakagaki K, Matsuyama S, Taguchi F (2014) Possible involvement of infection with human coronavirus 229E, but not NL63 in, Kawasaki disease. J Med Virol 86(12):2146–2153 Rivas MN, Wakita D, Franklin MK, Carvalho TT, Abolhesn A, Gomez AC et al (2019) Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity 51(3):508-521.e6 Rowley AH, Wylie KM, Kim KYA, Pink AJ, Yang A, Reindel R et al (2015) The transcriptional profile of coronary arteritis in Kawasaki disease. BMC Genom 16(1):1076 Wright VJ, Herberg JA, Kaforou M, Shimizu C, Eleftherohorinou H, Shailes H et al (2018) Diagnosis of Kawasaki disease using a minimal whole-blood gene expression signature. JAMA Pediatr 172(10):e182293–e182293 Popper SJ, Watson VE, Shimizu C, Kanegaye JT, Burns JC, Relman DA (2009) Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis 200(4):657–666 Hoang LT, Shimizu C, Ling L, Naim ANM, Khor CC, Tremoulet AH et al (2014) Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med 6(11):541 Giordani L, Quaranta MG, Marchesi A, Straface E, Pietraforte D, Villani A et al (2011) Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease. Clin Exp Immunol 163(3):346–353 Xu M, Jiang Y, Wang J, Liu J, Liu C, Liu D et al (2019) Distinct variations of antibody secreting cells and memory B cells during the course of Kawasaki disease. BMC Immunol 20(1):16 Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC (2001) Oligoclonal IgA Response In The Vascular Wall In Acute Kawasaki Disease. J Immunol 166(2):1334–1343 Rowley AH, Shulman ST, Garcia FL, Guzman-Cottrill JA, Miura M, Lee HL et al (2005) Cloning the arterial IgA antibody response during acute Kawasaki disease. J Immunol 175(12):8386–8391 Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B et al (2020) Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol 217:108487 Blanchard JN, Powell HC, Freeman WR, Letendre S, Blanchard D, Shimizu C et al (2003) Recurrent Kawasaki disease—like syndrome in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 36(1):105–111 Johnson RM, Bergmann KR, Manaloor JJ, Yu X, Slaven JE, Kharbanda AB (2016) Pediatric Kawasaki disease and adult human immunodeficiency virus Kawasaki-like syndrome are likely the same malady. Open Forum Infect Dis 3(3):ofw160. https://doi.org/10.1093/ofid/ofw160 Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C et al (2020) Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Investig. https://doi.org/10.1172/JCI140970 Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J et al (2020) Multisystem inflammatory syndrome in children in New York State. N Engl J Med 383(4):347–358 Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D et al (2020) Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 10(1):69 Nasir A, Al Tatari H, Hamdan MA (2012) Very high serum ferritin levels in three newborns with Kawasaki-like illness. Paediatr Child Health 17(4):201–204 Carnevale S, Beretta P, Morbini P (2020) Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. J Med Virol. https://doi.org/10.1002/jmv.26119 (Epub ahead of print) Gruber C, Patel R, Trachman R, Lepow L, Amanat F, Krammer F, et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). medRxiv. 2020;2020.07.04.20142752. Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L et al (2020) The Immunology of multisystem inflammatory syndrome in children with COVID-19. Cell S0092–8674(20):31157 Sakurai Y (2019) Autoimmune aspects of Kawasaki DISEASE. J Investig Allergol Clin Immunol 29(4):251–261 Manson JJ, Crooks C, Naja M, Ledlie A, Goulden B, Liddle T et al (2020) COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study. Lancet Rheumatol 2(10):e594-602 Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A et al (2020) Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. https://doi.org/10.1016/S2665-9913(20)30343-X (Epub ahead of print) Sokolovsky S, Soni P, Hoffman T, Kahn P, Scheers-Masters J (2020) COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am J Emerg Med. https://doi.org/10.1016/j.ajem.2020.06.053 (Epub ahead of print) Shaigany S, Gnirke M, Guttmann A, Chong H, Meehan S, Raabe V et al (2020) An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19. Lancet 396(10246):e8-10 Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S et al (2020) Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection—United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep 69(40):1450–1456. https://doi.org/10.15585/mmwr.mm6940e1 Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y et al (2020) Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med 26(4):502–505 Cohen R, Jung C, Ouldali N, Sellam A, Batard C, Cahn-Sellem F, et al. Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic. medRxiv. 2020;2020.06.12.20129221. Lassaunière R, Frische A, Harboe ZB, Nielsen AC, Fomsgaard A, Krogfelt KA et al (2020) Evaluation of nine commercial SARS-CoV-2 immunoassays. Medrxiv. https://doi.org/10.1101/2020.04.09.20056325 Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K et al (2020) Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 26(6):845–848 Gazzaruso C, Carlo Stella N, Mariani G, Nai C, Coppola A, Naldani D et al (2020) High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clin Rheumatol 39(7):2095–2097